Enpp-1-IN-5
CAT:
804-HY-145063-01
Size:
5 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
Enpp-1-IN-5
- CAS Number: 2230916-95-5
- UNSPSC Description: Enpp-1-IN-5 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1). The ENPP 1 has broad specificity and can cleave a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds nucleotides and nucleotide sugars. Enpp-1-IN-5 has the potential for the research of cancer and infectious diseases (extracted from patent WO2019046778A1/WO2021203772A1, compound 1)[1][2].
- Target Antigen: Phosphodiesterase (PDE)
- Type: Reference compound
- Related Pathways: Metabolic Enzyme/Protease
- Applications: COVID-19-immunoregulation
- Field of Research: Cancer; Infection; Inflammation/Immunology
- Assay Protocol: https://www.medchemexpress.com/enpp-1-in-5.html
- Solubility: DMSO : 100 mg/mL (ultrasonic)
- Smiles: O=S(N)(NCCC1CCN(CC1)C2=C3C=C(OC)C(OC)=CC3=NC(N)=N2)=O
- Molecular Weight: 410.49
- References & Citations: [1]William Michael Gallatin, et al. Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof. Patent WO2019046778A1.|[2]Bang Fu, et al. Ectonucleotide pyrophosphatase-phosphodiesterase 1 inhibitors,compositions and uses thereof. Patent WO2021203772A1.
- Shipping Conditions: Room Temperature
- Clinical Information: No Development Reported